Biowatch

Stray Kids’ Felix Donates 100 Million KRW Each to SNU Children’s Hospital and Samsung Medical Center

Stray Kids’ Felix Donates 100 Million KRW Each to SNU Children’s Hospital and Samsung Medical Center

Stray Kids member Felix has donated 100 million KRW each to Seoul National University Children’s Hospital and Samsung Medical Center on his birthday...
Celltrion Files Phase 4 IND with FDA to Support 240 mg High-Dose Zymfentra Regimen in US

Celltrion Files Phase 4 IND with FDA to Support 240 mg High-Dose Zymfentra Regimen in US

Celltrion has submitted an Investigational New Drug application to the U.S. Food and Drug Administration for a Phase 4 clinical trial of Zymfentra...
Yuhan Corp. Launches Drinkable Joint Supplement 'Yuhan Chondroitin 1200'

Yuhan Corp. Launches Drinkable Joint Supplement 'Yuhan Chondroitin 1200'

Yuhan Corp. announced on Aug. 31 that it will launch "Yuhan Chondroitin 1200," a liquid joint and cartilage health...
Celltrion Targets 33% Shareholder Payout Ratio, Adds 100 Billion Won Share Buyback

Celltrion Targets 33% Shareholder Payout Ratio, Adds 100 Billion Won Share Buyback

Celltrion announced on Aug. 31 that it will return approximately one-third of its annual consolidated net profit to...
Samsung Biologics to Raise ₩3 Trillion in Rights Offering to Fund ₩2.7 Trillion Acquisition of PolyPeptide Group

Samsung Biologics to Raise ₩3 Trillion in Rights Offering to Fund ₩2.7 Trillion Acquisition of PolyPeptide Group

Samsung Biologics is proceeding with a 3 trillion won ($2.25 billion) rights offering, directing approximately 90% of...
Customizable Artificial Ear Bone Allows Fine-Tuning During Surgery to Restore Hearing

Customizable Artificial Ear Bone Allows Fine-Tuning During Surgery to Restore Hearing

Patients suffering from conductive hearing loss caused by damaged middle ear bones may soon benefit from a new surgical...
Celltrion to Select Japanese Biotech Startups for Joint R&D and Pipeline Expansion

Celltrion to Select Japanese Biotech Startups for Joint R&D and Pipeline Expansion

Celltrion is stepping up efforts to identify and foster promising biotech startups in Japan.
Kyungdong Pharmaceutical and AUL Bio Seek Phase 1 Approval for Once-Monthly Obesity Drug AUL009

Kyungdong Pharmaceutical and AUL Bio Seek Phase 1 Approval for Once-Monthly Obesity Drug AUL009

Kyungdong Pharmaceutical announced Sept. 2 that it has submitted an investigational new drug application to the...
Skin Aging Is More Than Collagen Loss: GC Green Cross Wellbeing Unveils Next-Gen ECM Booster in the Philippines

Skin Aging Is More Than Collagen Loss: GC Green Cross Wellbeing Unveils Next-Gen ECM Booster in the Philippines

When skin begins to sag and lose its glow, many people attribute the change solely to declining collagen.
Hanmi Completes Key Phase 2 Dosing for Once-Weekly Rare Disease Drug Efpeglucagon

Hanmi Completes Key Phase 2 Dosing for Once-Weekly Rare Disease Drug Efpeglucagon

During normal digestion, dietary carbohydrates convert into glucose that circulates in the blood.